Share price vs Emotional state: Don't combine, mix, or

New Post Public Reply Private Reply Replies (0) Message Board
joey68
132
Share price vs Emotional state: Don't combine, mix, or stir

When you invest, do you notice your emotional state parallels the share price?

High share price = Happy
Low share price = Sad
Rising share price = Happy
Falling share price = Sad

If so, you may be investing based on emotions rather than DD. If you have been investing for over a year yet have never made a penny in profits, your emotions may be getting the better of you.

It is extremely difficult to separate emotions from investing. So much so that there are charts outlining the emotional connection to your investment decisions:

SjWCJ5b.png

Most investors never learn to separate the two; causing them to never make a profit. They sell when they are mad, buy when they are happy, sell when the price falls, and never buys more when the price rises.

How investing should work:

Buy when DD indicates
Sell when DD indicates
Sell when you meet your investment goal

Very difficult to do, especially since humans are emotional by nature.

Not investment advice
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 1

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
China's Manufacturing: Squeeze or Opportunity?

Updated Category News Views 3

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
D-Wave Hit with Legal Scrutiny After Disappointing Q2

Updated Category News Views 1

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading

Top 5 Most Recently Viewed Articles

Archer Aviation's Q4 Earnings Report: Key Insights and Future Plans

Updated Category News Views 344

Archer Aviation Reports Q4 Earnings and Future Plans Archer Aviation Inc (ACHR) has recently disclosed its financial results for the fourth quarter of the fiscal year. This report provides an in-depth look at crucial details associated with their recent earnings and future strategies. Understanding Archer's Q4 Financial Performance During the fourth quarter, Archer...

Continue Reading
Alvotech's Progress on FDA Review for AVT05 Biosimilar

Updated Category News Views 265

Alvotech's Update on AVT05 Biologics License Application Alvotech (NASDAQ: ALVO), a prominent global biotech firm dedicated to crafting biosimilar medicines, recently announced significant developments regarding its Biologics License Application (BLA) for AVT05. This biosimilar candidate, designed to imitate Simponi (golimumab), is being presented in both prefilled...

Continue Reading
Benzinga Honors Fintech Innovators at Capital Conference 2025

Updated Category News Views 199

Benzinga Celebrates the Best in Fintech Innovations Benzinga, a standout leader in financial media and data, held an extraordinary event celebrating the annual Fintech Awards. The event recognized remarkable achievements shaping the future of the financial sector, inspiring executives and innovators alike. A Night of Glorious Recognition The awards ceremony was a...

Continue Reading
Understanding the Decline in Eastern Bankshares Short Interest

Updated Category News Views 107

Overview of Eastern Bankshares Short Interest Eastern Bankshares EBC has witnessed a reduction in its short interest, which is a metric used by investors to gauge market sentiment. Recently, the short percent of float dropped by 3.96%. The company reported approximately 4.26 million shares sold short, equating to about 2.18% of all shares available for trading. Given its...

Continue Reading
Promising Results from enGene's Bladder Cancer Trial Excite Investors

Updated Category News Views 121

Excitement in the Air for enGene Holdings Inc. enGene Holdings Inc. (NASDAQ: ENGN) is experiencing a significant surge in its stock price as more promising data emerges from its ongoing clinical trials. As of the latest reporting period, the company's stock surged higher, showcasing a remarkable increase. This positive upward momentum coincides with the release of the new...

Continue Reading